Peripheral Neuropathy Trial, Recruiting NCT07414069 Sponsor: Ankara City Hospital Bilkent Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07414069
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • You have symptoms that match carpal tunnel syndrome
  • A nerve conduction test has confirmed you have mild or moderate carpal tunnel syndrome
  • You are able to follow the study's requirements and attend all follow-up appointments
  • You are willing and able to sign a consent form to take part

Who may not be able to join:

  • Your nerve conduction test shows severe carpal tunnel syndrome
  • You have previously had surgery for carpal tunnel syndrome
  • Your carpal tunnel syndrome is caused by a physical growth or cyst in the wrist area
  • You have a health condition linked to carpal tunnel syndrome, such as diabetes, an underactive thyroid, pregnancy, or a growth hormone disorder
  • You have received a steroid injection for carpal tunnel syndrome in the last 6 months
  • You have nerve problems affecting multiple nerves, a pinched nerve in your neck/spine, or other nerve conditions affecting your arm or hand
  • You have any reason you cannot safely have nerve conduction testing or laser therapy (confirm with trial site)
  • You are unable to attend or complete all follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Filiz Eser, professor, Ankara City Hospital Bilkent

Phone: +905312689928

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara City Hospital Bilkent
Registry
ClinicalTrials.gov
Start date
2 November 2025
Est. completion
5 March 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Pain Severity assessed by Visual Analog Scale (VAS); Symptom Severity and Functional Status assessed by Boston Carpal Tunnel Questionnaire (BCTQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov